Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I Guest UserJanuary 26, 2022
Akili Founders Recognized by Newsweek on Inaugural List of America’s 50 Greatest Disruptors Guest UserDecember 17, 2021
Topline Results from Shionogi Phase 2 Study in Japan Show Akili’s Digital Treatment Was Well-received and Improved Inattention Symptoms in Children with ADHD Guest UserSeptember 29, 2021
Akili Announces EndeavorRx® is Now Available on Android™ Devices, Expanding Access for Children with ADHD Guest UserSeptember 16, 2021
Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive Impairments Guest UserAugust 17, 2021
Akili Releases New Gameplay Features in the First and Only FDA-Cleared Video Game Treatment for Children with ADHD Guest UserJuly 22, 2021
Akili Secures $160 Million in Financing; Poised to Deliver on the Promise of Digital Therapeutics Guest UserMay 26, 2021
Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL-T01 as Treatment for COVID Brain Fog Guest UserApril 7, 2021
Researchers Present New Outcome Data for Akili Digital Therapeutic EndeavorRx™ in Pediatric ADHD Guest UserOctober 21, 2020
Akili Announces CE Mark Approval of EndeavorRx™ Digital Treatment for Children with ADHD Guest UserJune 23, 2020
Akili Announces FDA Clearance of EndeavorRx™ for Children with ADHD, the First Prescription Treatment Delivered Through a Video Game Guest UserJune 15, 2020
Akili Announces Publication of AKL-T01 ADHD Pivotal Study Results in the Lancet Digital Health Guest UserFebruary 24, 2020
Akili Study of AKL-T01 With and Without Stimulant Medication in Children with ADHD Achieves Primary Efficacy Endpoint Guest UserJanuary 15, 2020
Akili Technology Improves Cognitive Impairments in Adults with Major Depressive Disorder Guest UserDecember 12, 2019
Akili Grows Leadership Team with Chief Financial Officer and General Counsel Appointments Guest UserApril 11, 2019
Akili and Shionogi Announce Strategic Partnership to Develop and Commercialize Digital Therapeutics in Key Asian Markets Guest UserMarch 7, 2019
Akili Builds Medical Team with Newly Appointed Medical Affairs Leader and Formation of Clinical Advisory Committee in Preparation for Commercial Launch Guest UserNovember 13, 2018
Akili Announces Exclusive Licensing Agreement for New Digital Technology Integrating Neural Systems Targeting and Physical Activity as Novel Cognitive Dysfunction Treatment Platform Guest UserSeptember 12, 2018
Akili Raises Additional $13 Million, Bringing Total Series C Funding to $68 Million Guest UserAugust 9, 2018
